PL175365B1 - Etery O-arylowe morfinanów, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczne - Google Patents
Etery O-arylowe morfinanów, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczneInfo
- Publication number
- PL175365B1 PL175365B1 PL94301784A PL30178494A PL175365B1 PL 175365 B1 PL175365 B1 PL 175365B1 PL 94301784 A PL94301784 A PL 94301784A PL 30178494 A PL30178494 A PL 30178494A PL 175365 B1 PL175365 B1 PL 175365B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- morphinan
- methyl
- group
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US113593A | 1993-01-06 | 1993-01-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL301784A1 PL301784A1 (en) | 1994-07-11 |
| PL175365B1 true PL175365B1 (pl) | 1998-12-31 |
Family
ID=21694554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL94301784A PL175365B1 (pl) | 1993-01-06 | 1994-01-05 | Etery O-arylowe morfinanów, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczne |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0612730B1 (show.php) |
| JP (1) | JP2501298B2 (show.php) |
| KR (1) | KR940018094A (show.php) |
| CN (1) | CN1097006A (show.php) |
| AT (1) | ATE154931T1 (show.php) |
| AU (1) | AU681601B2 (show.php) |
| BR (1) | BR9400021A (show.php) |
| CA (1) | CA2110337A1 (show.php) |
| CZ (1) | CZ2294A3 (show.php) |
| DE (1) | DE69311887T2 (show.php) |
| DK (1) | DK0612730T3 (show.php) |
| ES (1) | ES2105061T3 (show.php) |
| FI (1) | FI940041L (show.php) |
| GR (1) | GR3024891T3 (show.php) |
| HU (2) | HUT66061A (show.php) |
| IL (1) | IL108247A (show.php) |
| MX (1) | MX9400177A (show.php) |
| NO (1) | NO940028D0 (show.php) |
| NZ (1) | NZ250580A (show.php) |
| PL (1) | PL175365B1 (show.php) |
| TW (1) | TW264473B (show.php) |
| UY (1) | UY23706A1 (show.php) |
| ZA (1) | ZA939806B (show.php) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522176D0 (en) * | 1995-10-30 | 1996-01-03 | Iaf Biochem Int | Morphinan derivatives having neuroprotective activity |
| DE69739561D1 (de) * | 1996-06-13 | 2009-10-15 | Sumitomo Chemical Co | Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung |
| FR2752163B1 (fr) * | 1996-08-12 | 1998-10-30 | Pf Medicament | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington |
| GB9706753D0 (en) * | 1997-04-03 | 1997-05-21 | Pharmacia & Upjohn Spa | Aralkoxy-morphinan derivatives |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| WO2003097608A2 (en) * | 2002-05-17 | 2003-11-27 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
| US20040204862A1 (en) | 2003-04-11 | 2004-10-14 | Wainer Irving W. | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US8436174B2 (en) * | 2009-02-23 | 2013-05-07 | Mallinckrodt Llc | (+)-morphinanium quaternary salts and processes for their production |
| CN103044327B (zh) * | 2013-01-07 | 2014-12-17 | 苏州立新制药有限公司 | 一种右美沙芬的制备方法 |
| CN117427077A (zh) * | 2014-09-14 | 2024-01-23 | 阿瓦尼尔制药股份有限公司 | 用于治疗痴呆中的激越行为的包含右美沙芬化合物和奎尼丁的药物组合物 |
| US20160243112A1 (en) * | 2015-02-25 | 2016-08-25 | Alkermes, Inc. | Treatments for alzheimer's related diseases and disorders |
| CA3192609A1 (en) * | 2020-08-28 | 2022-03-03 | Nippon Chemiphar Co., Ltd. | Method for preparing morphinan derivative having diaryl ether skeleton using novel copper catalyst |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI773636A7 (fi) * | 1976-12-06 | 1978-06-07 | Hoffmann La Roche | Nya fenylderivat |
| US4113729A (en) * | 1976-12-06 | 1978-09-12 | Hoffmann-La Roche Inc. | 3-Phenoxymorphinans and derivatives thereof |
| US4806543A (en) * | 1986-11-25 | 1989-02-21 | Board Of Trustees Of The Leland Stanford Junior University | Method and compositions for reducing neurotoxic injury |
-
1993
- 1993-11-25 TW TW082109942A patent/TW264473B/zh active
- 1993-11-30 CA CA002110337A patent/CA2110337A1/en not_active Abandoned
- 1993-12-20 EP EP93120498A patent/EP0612730B1/en not_active Expired - Lifetime
- 1993-12-20 AT AT93120498T patent/ATE154931T1/de not_active IP Right Cessation
- 1993-12-20 DK DK93120498.6T patent/DK0612730T3/da active
- 1993-12-20 DE DE69311887T patent/DE69311887T2/de not_active Expired - Fee Related
- 1993-12-20 ES ES93120498T patent/ES2105061T3/es not_active Expired - Lifetime
- 1993-12-23 NZ NZ250580A patent/NZ250580A/en unknown
- 1993-12-30 ZA ZA939806A patent/ZA939806B/xx unknown
- 1993-12-30 JP JP5354172A patent/JP2501298B2/ja not_active Expired - Lifetime
- 1993-12-31 IL IL108247A patent/IL108247A/en not_active IP Right Cessation
- 1993-12-31 AU AU52807/93A patent/AU681601B2/en not_active Ceased
- 1993-12-31 UY UY23706A patent/UY23706A1/es unknown
-
1994
- 1994-01-03 MX MX9400177A patent/MX9400177A/es not_active IP Right Cessation
- 1994-01-03 HU HU9400002A patent/HUT66061A/hu unknown
- 1994-01-04 KR KR1019940000067A patent/KR940018094A/ko not_active Ceased
- 1994-01-04 NO NO940028A patent/NO940028D0/no unknown
- 1994-01-05 CZ CZ9422A patent/CZ2294A3/cs unknown
- 1994-01-05 FI FI940041A patent/FI940041L/fi unknown
- 1994-01-05 CN CN94100181A patent/CN1097006A/zh active Pending
- 1994-01-05 BR BR9400021A patent/BR9400021A/pt not_active Application Discontinuation
- 1994-01-05 PL PL94301784A patent/PL175365B1/pl unknown
-
1995
- 1995-06-19 HU HU95P/P00253P patent/HU211290A9/hu unknown
-
1997
- 1997-09-30 GR GR970402538T patent/GR3024891T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY23706A1 (es) | 1994-06-05 |
| EP0612730B1 (en) | 1997-07-02 |
| CA2110337A1 (en) | 1994-07-07 |
| FI940041A7 (fi) | 1994-07-07 |
| DE69311887T2 (de) | 1998-01-15 |
| BR9400021A (pt) | 1994-07-26 |
| ATE154931T1 (de) | 1997-07-15 |
| NO940028L (show.php) | 1994-07-07 |
| HUT66061A (en) | 1994-09-28 |
| JP2501298B2 (ja) | 1996-05-29 |
| AU5280793A (en) | 1994-07-14 |
| PL301784A1 (en) | 1994-07-11 |
| FI940041A0 (fi) | 1994-01-05 |
| CZ2294A3 (en) | 1994-07-13 |
| DE69311887D1 (de) | 1997-08-07 |
| HU9400002D0 (en) | 1994-05-30 |
| KR940018094A (ko) | 1994-08-16 |
| EP0612730A1 (en) | 1994-08-31 |
| GR3024891T3 (en) | 1998-01-30 |
| ZA939806B (en) | 1994-07-06 |
| CN1097006A (zh) | 1995-01-04 |
| IL108247A0 (en) | 1994-04-12 |
| JPH06316564A (ja) | 1994-11-15 |
| HU211290A9 (en) | 1995-11-28 |
| NZ250580A (en) | 1996-07-26 |
| DK0612730T3 (da) | 1998-02-02 |
| MX9400177A (es) | 1994-07-29 |
| FI940041L (fi) | 1994-07-07 |
| IL108247A (en) | 1998-02-22 |
| TW264473B (show.php) | 1995-12-01 |
| NO940028D0 (no) | 1994-01-04 |
| ES2105061T3 (es) | 1997-10-16 |
| AU681601B2 (en) | 1997-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2739968A (en) | Substituted piperidines | |
| DE69610822T2 (de) | Indolderivate als 5-ht rezeptorantagoniste | |
| PL175365B1 (pl) | Etery O-arylowe morfinanów, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczne | |
| SK113998A3 (en) | 6-phenylpyridyl-2-amine derivatives | |
| SK1402000A3 (en) | 2-aminopyridines containing fused ring substituents as nos inhibitors | |
| JP2006509748A (ja) | Ｇｓｋ−３ベータ阻害剤としてのピリダジノン誘導体 | |
| WO2001007411A1 (en) | Biarylurea derivatives | |
| SK70899A3 (en) | 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors | |
| JPH08502275A (ja) | ５−ｈｔ▲下４▼レセプターアンタゴニスト用複素環式縮合安息香酸誘導体 | |
| WO2004050650A1 (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| AU2006218125A1 (en) | Pyrrolidine and piperidine acetylene derivatives for use as mGluR5 antagonists | |
| EP1025100B1 (de) | 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung | |
| JP2012511514A (ja) | レニン阻害剤としての３，４−置換ピペリジン誘導体 | |
| JP2002220338A (ja) | ビアリールウレア化合物又はその塩を有効成分として含有するＣｄｋ４及び／又はＣｄｋ６阻害剤 | |
| SK12022001A3 (sk) | 2-aminopyridíny obsahujúce ako substituenty kondenzované kruhové skupiny | |
| US5925646A (en) | Heterocyclic aryl-, alkyl- and cycloalkylacetamides | |
| US5118691A (en) | Substituted tetrahydropyridines as central nervous system agents | |
| US5045550A (en) | Substituted tetrahydropyridines as central nervous system agents | |
| AP1208A (en) | 2-Aminopyridines containing fused ring substituents | |
| HU188475B (en) | Process for producing benzothiopyrano-pyridinones | |
| EP0657459A1 (de) | Neue Thienothiazinderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Antiinflammatorikum und Analgeticum | |
| US5187280A (en) | Substituted tetrahydropyridines and their use as central nervous system agents | |
| Shafik et al. | Synthesis of novel 2-[2-(substituted amino) phenethyl]-1H-benzimidazoles; 3, 4-dihydro and 1, 2, 3, 4,-tetrahydropyrimido [1, 6-a]-benzimidazoles as potential antiulcer agents | |
| RU2123000C1 (ru) | О-арильные эфиры морфинанов, фармацевтическая композиция | |
| US20040077853A1 (en) | 2-amino-6-(2,4,5-substituted-phenyl)-pyridines |